尿沉渣异形红细胞诊断肾小球肾炎:特异性高但敏感性低
该单中心回顾性研究纳入482例成人肾活检患者,评估尿沉渣异形红细胞(dRBCs)≥25%与肾小球疾病的关系。结果显示该阈值诊断肾小球疾病的敏感性20.4%、特异性96.3%、阳性预测值94.6%,但多因素回归中仅尿红细胞>10/HPF(P<0.001)而非dRBCs≥25%(P=0.3)独立预测GN。基于血尿和蛋白尿的0-3评分可预测活检证实的GN风险(0分15% vs 3分83%)。
要点
- 尿dRBCs≥25%对GN特异性高(96.3%)但敏感性低(20.4%),阴性不能排除GN。
- 尿红细胞>10/HPF独立预测GN(P<0.001),而dRBCs≥25%无独立预测价值(P=0.3)。
- 血尿联合蛋白尿的0-3评分可分层GN风险:0分15%,3分83%。
核心结论
- 尿dRBCs≥25%对GN特异性高但不敏感,联合血尿和蛋白尿的评分模型可预测活检证实的GN。
研究设计与样本
- 单中心回顾性研究,纳入2012-2015年接受肾活检且同期有尿常规的成人患者482例,平均年龄55岁,女性47.7%。
主要发现
- 173例(35.9%)dRBCs<25%,76例(15.8%)dRBCs≥25%;肾活检显示372例(77.2%)为肾小球疾病(GN 46%,非GN 54%)。
- dRBCs≥25%诊断肾小球疾病的敏感性20.4%、特异性96.3%、阳性预测值94.6%。
- 多因素回归中尿红细胞>10/HPF vs ≤10(P<0.001)独立预测GN,而dRBCs≥25%(P=0.3)无独立预测价值。
- 基于血尿和蛋白尿水平的0-3评分:0分时活检证实的GN风险为15%,3分时为83%。
关键数值与推荐
- dRBCs阈值≥25%用于诊断肾小球疾病:敏感性20.4%、特异性96.3%、阳性预测值94.6%。
- 尿红细胞>10/HPF(P<0.001)独立预测GN,dRBCs≥25%(P=0.3)不独立预测。
- 血尿联合蛋白尿0-3评分:0分GN风险15%,3分GN风险83%。
临床怎么用
- dRBCs≥25%可高度提示GN,但阴性结果不能排除GN,需结合血尿和蛋白尿综合评估。
- 血尿>10/HPF联合蛋白尿的评分有助于判断GN风险并指导肾活检决策。
局限性
- 单中心回顾性设计,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dysmorphic red blood cells (dRBCs) on urine microscopy have been associated with glomerulonephritis (GN). We assessed the prevalence and ability of dRBCs to differentiate GN from other kidney diseases. METHODS: Adult patients with kidney biopsy performed between 2012 and 2015 at a single center who had a concurrent urinalysis were retrospectively studied. The association of ≥25% dRBCs with the presence of glomerular pathology was assessed. Univariate and multivariate logistic regression were performed on significantly associated variables. RESULTS: The mean age of the 482 eligible subjects was 55 years and 47.7% were female. Overall, 173 (35.9%) had <25% and 76 (15.8%) had ≥25% urine dRBCs. Kidney biopsies revealed glomerular disease in 372 (77.2%) (GN 46% and non-GN 54%). At the dRBC threshold of ≥25% used at our center, a sensitivity of 20.4%, specificity of 96.3% and positive predictive value of 94.6% for glomerular disease were observed. In a logistic regression model, urine RBCs [>10 versus ≤10 (P < 0.001)] but not dRBCs ≥25% (P = 0.3) independently predicted the presence of GN. A scoring system (0-3) based on hematuria and proteinuria levels revealed the risk for biopsy-proven GN was 15% when the score was 0 compared with 83% when it was 3. CONCLUSIONS: The presence of ≥25% urine dRBCs is specific but not sensitive for GN. In this cohort, the combined hematuria (>10 RBCs/high-power field) and proteinuria performed just as well as dRBCs plus proteinuria to predict underlying GN. A model based on the degree of hematuria and proteinuria found on urinalysis was able to predict the presence of GN.
引用
- Hamadah AM, Gharaibeh K, Mara KC, et al. Urinalysis for the diagnosis of glomerulonephritis: role of dysmorphic red blood cells. Nephrol Dial Transplant. 2018. PMID: 29156008. doi:10.1093/ndt/gfx274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。